Development and validation of ultra-performance liquid chromatographic method with tandem mass spectrometry for determination of lenalidomide in rabbit and human plasma

BACKGROUND: Lenalidomide (LND) is a potent novel thalidomide analog which demonstrated remarkable clinical activity in treatment of multiple myeloma disease via a multiple-pathways mechanism. Validated sensitive method with high throughput is required for the determination of lenalidomide for pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Muzaffar, Wani, Tanveer A, Khalil, Nasr Y, Darwish, Ibrahim A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608328/
https://www.ncbi.nlm.nih.gov/pubmed/23316845
http://dx.doi.org/10.1186/1752-153X-7-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608328/
https://www.ncbi.nlm.nih.gov/pubmed/23316845
http://dx.doi.org/10.1186/1752-153X-7-7

Ejemplares similares